124 related articles for article (PubMed ID: 18160777)
21. p16INK4A (CDKN2A) gene deletion is a frequent genetic event in synovial sarcomas.
Subramaniam MM; Noguera R; Piqueras M; Navarro S; López-Guerrero JA; Llombart-Bosch A
Am J Clin Pathol; 2006 Dec; 126(6):866-74. PubMed ID: 17074682
[TBL] [Abstract][Full Text] [Related]
22. Procholecystokinin as marker of human Ewing sarcomas.
Reubi JC; Koefoed P; Hansen Tv; Stauffer E; Rauch D; Nielsen FC; Rehfeld JF
Clin Cancer Res; 2004 Aug; 10(16):5523-30. PubMed ID: 15328192
[TBL] [Abstract][Full Text] [Related]
23. Identification and characterization of a homozygous deletion found in ovarian ascites by representational difference analysis.
Watson JE; Gabra H; Taylor KJ; Rabiasz GJ; Morrison H; Perry P; Smyth JF; Porteous DJ
Genome Res; 1999 Mar; 9(3):226-33. PubMed ID: 10077528
[TBL] [Abstract][Full Text] [Related]
24. p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a.
Krimpenfort P; Ijpenberg A; Song JY; van der Valk M; Nawijn M; Zevenhoven J; Berns A
Nature; 2007 Aug; 448(7156):943-6. PubMed ID: 17713536
[TBL] [Abstract][Full Text] [Related]
25. The NFATc2 gene is involved in a novel cloned translocation in a Ewing sarcoma variant that couples its function in immunology to oncology.
Szuhai K; Ijszenga M; de Jong D; Karseladze A; Tanke HJ; Hogendoorn PC
Clin Cancer Res; 2009 Apr; 15(7):2259-68. PubMed ID: 19318479
[TBL] [Abstract][Full Text] [Related]
26. Identification of chromosome arm 9p as the most frequent target of homozygous deletions in lung cancer.
Sato M; Takahashi K; Nagayama K; Arai Y; Ito N; Okada M; Minna JD; Yokota J; Kohno T
Genes Chromosomes Cancer; 2005 Dec; 44(4):405-14. PubMed ID: 16114034
[TBL] [Abstract][Full Text] [Related]
27. Hyperdiploidy with trisomy 9 and deletion of the CDKN2A locus in T-cell acute lymphoblastic leukemia.
Healey K; Gray SL; Halligan GE; McKenzie AS; de Chadarévian JP; Morrissette JJ
Cancer Genet Cytogenet; 2009 Apr; 190(2):121-4. PubMed ID: 19380031
[TBL] [Abstract][Full Text] [Related]
28. Cytogenetic and molecular cytogenetic studies of a variant of t(21;22), ins(22;21)(q12;q21q22), with a deletion of the 3' EWSR1 gene in a patient with Ewing sarcoma.
Lee J; Hopcus-Niccum DJ; Mulvihill JJ; Li S
Cancer Genet Cytogenet; 2005 Jun; 159(2):177-80. PubMed ID: 15899394
[TBL] [Abstract][Full Text] [Related]
29. 9p21 Deletion in the diagnosis of malignant mesothelioma in serous effusions additional to immunocytochemistry, DNA-ICM, and AgNOR analysis.
Onofre FB; Onofre AS; Pomjanski N; Buckstegge B; Grote HJ; Böcking A
Cancer; 2008 Jun; 114(3):204-15. PubMed ID: 18306350
[TBL] [Abstract][Full Text] [Related]
30. Morphology of 9p21 homozygous deletion-positive pleural mesothelioma cells analyzed using fluorescence in situ hybridization and virtual microscope system in effusion cytology.
Matsumoto S; Nabeshima K; Kamei T; Hiroshima K; Kawahara K; Hata S; Marukawa K; Matsuno Y; Taguchi K; Tsujimura T
Cancer Cytopathol; 2013 Aug; 121(8):415-22. PubMed ID: 23450849
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of methylthioadenosin phosphorylase by homozygous deletion in gastric carcinoma.
Kim J; Kim MA; Min SY; Jee CD; Lee HE; Kim WH
Genes Chromosomes Cancer; 2011 Jun; 50(6):421-33. PubMed ID: 21412930
[TBL] [Abstract][Full Text] [Related]
32. The gene for the cyclin-dependent-kinase-4 inhibitor, CDKN2A, is preferentially deleted in malignant mesothelioma.
Prins JB; Williamson KA; Kamp MM; Van Hezik EJ; Van der Kwast TH; Hagemeijer A; Versnel MA
Int J Cancer; 1998 Feb; 75(4):649-53. PubMed ID: 9466670
[TBL] [Abstract][Full Text] [Related]
33. Localization of genetic elements of intact and derivative chromosome 11 and 22 territories in nuclei of Ewing sarcoma cells.
Taslerová R; Kozubek S; Bártová E; Gajdusková P; Kodet R; Kozubek M
J Struct Biol; 2006 Sep; 155(3):493-504. PubMed ID: 16837212
[TBL] [Abstract][Full Text] [Related]
34. Complex patterns of chromosome 9 alterations including the p16INK4a locus in Wilms tumours.
Natrajan R; Warren W; Messahel B; Reis-Filho JS; Brundler MA; Dome JS; Grundy PE; Vujanic G; Pritchard-Jones K; Jones C
J Clin Pathol; 2008 Jan; 61(1):95-102. PubMed ID: 17369505
[TBL] [Abstract][Full Text] [Related]
35. Molecular alterations at chromosome 9p21 in melanocytic naevi and melanoma.
Sini MC; Manca A; Cossu A; Budroni M; Botti G; Ascierto PA; Cremona F; Muggiano A; D'Atri S; Casula M; Baldinu P; Palomba G; Lissia A; Tanda F; Palmieri G
Br J Dermatol; 2008 Feb; 158(2):243-50. PubMed ID: 18028495
[TBL] [Abstract][Full Text] [Related]
36. Detection and molecular cytogenetic characterization of a novel ring chromosome in a histological variant of Ewing sarcoma.
Szuhai K; IJszenga M; Tanke HJ; Taminiau AH; de Schepper A; van Duinen SG; Rosenberg C; Hogendoorn PC
Cancer Genet Cytogenet; 2007 Jan; 172(1):12-22. PubMed ID: 17175374
[TBL] [Abstract][Full Text] [Related]
37. BRAF V600E mutation and 9p21: CDKN2A/B and MTAP co-deletions - Markers in the clinical stratification of pediatric gliomas.
Frazão L; do Carmo Martins M; Nunes VM; Pimentel J; Faria C; Miguéns J; Sagarribay A; Matos M; Salgado D; Nunes S; Mafra M; Roque L
BMC Cancer; 2018 Dec; 18(1):1259. PubMed ID: 30558563
[TBL] [Abstract][Full Text] [Related]
38. High-density genome array is superior to fluorescence in-situ hybridization analysis of monosomy 3 in choroidal melanoma fine needle aspiration biopsy.
Young TA; Burgess BL; Rao NP; Gorin MB; Straatsma BR
Mol Vis; 2007 Dec; 13():2328-33. PubMed ID: 18199974
[TBL] [Abstract][Full Text] [Related]
39. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
[TBL] [Abstract][Full Text] [Related]
40. p16ink4 immunoreactivity is a reliable marker for urothelial carcinoma in situ.
Yin M; Bastacky S; Parwani AV; McHale T; Dhir R
Hum Pathol; 2008 Apr; 39(4):527-35. PubMed ID: 18234280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
